These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1722669)

  • 21. Postmitotic differentiation of rat lung fibroblasts: induction by bleomycin and effect on prolyl 4-hydroxylase.
    Koslowski R; Morgner J; Seidel D; Knoch KP; Kasper M
    Exp Toxicol Pathol; 2004 Jul; 55(6):481-7. PubMed ID: 15384253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facilitation of electroporative drug uptake and cell killing by electrosensitization.
    Pakhomova ON; Gregory BW; Pakhomov AG
    J Cell Mol Med; 2013 Jan; 17(1):154-9. PubMed ID: 23305510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol.
    Mir LM; Banoun H; Paoletti C
    Exp Cell Res; 1988 Mar; 175(1):15-25. PubMed ID: 3345798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The disaccharide moiety of bleomycin facilitates uptake by cancer cells.
    Schroeder BR; Ghare MI; Bhattacharya C; Paul R; Yu Z; Zaleski PA; Bozeman TC; Rishel MJ; Hecht SM
    J Am Chem Soc; 2014 Oct; 136(39):13641-56. PubMed ID: 25184545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bleomycin: revival of an old drug.
    Mir LM; Tounekti O; Orlowski S
    Gen Pharmacol; 1996 Jul; 27(5):745-8. PubMed ID: 8842674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of cell membrane electropermeabilization by means of a nonpermeant cytotoxic agent.
    Kotnik T; Macek-Lebar A; Miklavcic D; Mir LM
    Biotechniques; 2000 May; 28(5):921-6. PubMed ID: 10818698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of a monoclonal antibody-bleomycin conjugate utilizing dextran T-40 and the antigen-targeting cytotoxicity of the conjugate.
    Manabe Y; Tsubota T; Haruta Y; Okazaki M; Haisa S; Nakamura K; Kimura I
    Biochem Biophys Res Commun; 1983 Sep; 115(3):1009-14. PubMed ID: 6194796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electropermeabilization in bladder cancer chemotherapy.
    Kubota Y; Nakada T; Yanai H; Kakizaki H; Sasagawa I; Watanabe M
    Cancer Chemother Pharmacol; 1996; 39(1-2):67-70. PubMed ID: 8995501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromatin condensation and differential sensitivity of mammalian and insect cells to DNA strand breaks induced by bleomycin.
    López-Larraza DM; Padrón J; Ronci NE; Vidal Rioja LA
    Mutat Res; 2006 Aug; 600(1-2):93-101. PubMed ID: 16620879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of hyperthermia with bleomycin and liblomycin: effects on CHO cells in vitro.
    Dogramatzis D; Nishikawa K; Newman RA
    Anticancer Res; 1991; 11(3):1359-64. PubMed ID: 1716087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential survival of cell subpopulations in spheroids after treatment with bleomycin.
    Tobüren D
    J Cancer Res Clin Oncol; 1981; 102(2):189-93. PubMed ID: 6175649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleomycin cytotoxicity is prevented by superoxide dismutase in vitro.
    Cunningham ML; Ringrose PS; Lokesh BR
    Cancer Lett; 1983 Dec; 21(2):149-53. PubMed ID: 6197159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs.
    Gehl J; Skovsgaard T; Mir LM
    Anticancer Drugs; 1998 Apr; 9(4):319-25. PubMed ID: 9635922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new method for permeabilization of the plasma membrane of cultured mammalian cells. IV. Structural requirement for high molecular weight polymers for potentiation of bleomycin cytotoxicity toward mammalian cells under conditions of vortex-stirring.
    Shimizu N; Nakamura M; Azuchi M; Okada M; Kawazoe Y
    Biol Pharm Bull; 1996 Sep; 19(9):1126-9. PubMed ID: 8889028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrochemotherapy on liver tumours in rabbits.
    Ramirez LH; Orlowski S; An D; Bindoula G; Dzodic R; Ardouin P; Bognel C; Belehradek J; Munck JN; Mir LM
    Br J Cancer; 1998 Jun; 77(12):2104-11. PubMed ID: 9649121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of cytotoxic effect of bleomycin with transient permeabilization of plasma membrane by laser-induced multiple stress waves in vitro.
    Miyamoto Y; Umebayashi Y; Koyano M; Wakita M; Nishisaka T
    Cancer Lett; 2003 Sep; 199(1):45-51. PubMed ID: 12963122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA response to bleomycin in mammalian cells with variable degrees of chromatin condensation.
    Lopez-Larraza DM; Bianchi NO
    Environ Mol Mutagen; 1993; 21(3):258-64. PubMed ID: 7681776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivities of bleomycin-resistant variant cells enhanced by 40 degrees C hyperthermia in vitro.
    Kano E; Furukawa-Furuya M; Nitta K; Kajimoto-Kinoshita T; Picha P; Sugimoto K; Ohtsubo T; Tsuji K; Tsubouchi S; Kondo T
    Int J Hyperthermia; 1988; 4(5):547-53. PubMed ID: 2455760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial single-strand DNA damage and cellular pharmacokinetics of bleomycin A2.
    Lazo JS; Schisselbauer JC; Meandzija B; Kennedy KA
    Biochem Pharmacol; 1989 Jul; 38(13):2207-13. PubMed ID: 2472141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bleomycin hydrolase activity in pulmonary cells.
    Lazo JS; Merrill WW; Pham ET; Lynch TJ; McCallister JD; Ingbar DH
    J Pharmacol Exp Ther; 1984 Dec; 231(3):583-8. PubMed ID: 6209387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.